Prosci/AADAC Antibody/30-042/100 ug,ProSci,,ProSci,prosci-inc,ProSci Incorporated,+,,Array.Array.Array蚂蚁淘厂家直采.

产品名称：Prosci/AADAC Antibody/30-042/100 ug

产品编号：30-042

市场价：¥6500.00

场地：美国(厂家直采)

产品分类：抗体类>一抗>重组抗体>

联系QQ：1570468124

电话号码：4000-520-616

邮箱： info@ebiomall.com

美元价：$325.00

品牌： ProSci

公司：ProSci Inc

公司分类：

商品介绍

Specifications

SPECIES REACTIVITY:	Human
TESTED APPLICATIONS:	ELISA, WB
APPLICATIONS:	AADAC antibody can be used for detection of AADAC by ELISA at 1:1562500. AADAC antibody can be used for detection of AADAC by western blot at 2.5 μg/mL, and HRP conjugated secondary antibody should be diluted 1:50,000 - 100,000.
USER NOTE:	Optimal dilutions for each application to be determined by the researcher.
POSITIVE CONTROL:	1) Cat. No. XBL-10409 - Fetal Liver Tissue Lysate
PREDICTED MOLECULAR WEIGHT:	44 kDa
IMMUNOGEN:	Antibody produced in rabbits immunized with a synthetic peptide corresponding a region of human AADAC.
HOST SPECIES:	Rabbit

Properties

PURIFICATION:	Antibody is purified by protein A chromatography method.
PHYSICAL STATE:	Lyophilized
BUFFER:	Antibody is lyophilized in PBS buffer with 2% sucrose. Add 100 μL of distilled water. Final antibody concentration is 1 mg/mL.
CONCENTRATION:	1 mg/ml
STORAGE CONDITIONS:	For short periods of storage (days) store at 4˚C. For longer periods of storage, store AADAC antibody at -20˚C. As with any antibody avoid repeat freeze-thaw cycles.
CLONALITY:	Polyclonal
CONJUGATE:	Unconjugated

Additional Info

ALTERNATE NAMES:	AADAC, DAC, CES5A1
ACCESSION NO.:	NP_001077
PROTEIN GI NO.:	68299767
OFFICIAL SYMBOL:	AADAC
GENE ID:	13

Background

BACKGROUND:	Microsomal arylacetamide deacetylase competes against the activity of cytosolic arylamine N-acetyltransferase, which catalyzes one of the initial biotransformation pathways for arylamine and heterocyclic amine carcinogens.Microsomal arylacetamide deacetylase competes against the activity of cytosolic arylamine N-acetyltransferase, which catalyzes one of the initial biotransformation pathways for arylamine and heterocyclic amine carcinogens.
REFERENCES:	1) Frick, C., (2004) J. Biol. Chem. 279 (30), 31131-31138.

BACKGROUND:

Microsomal arylacetamide deacetylase competes against the activity of cytosolic arylamine N-acetyltransferase, which catalyzes one of the initial biotransformation pathways for arylamine and heterocyclic amine carcinogens.Microsomal arylacetamide deacetylase competes against the activity of cytosolic arylamine N-acetyltransferase, which catalyzes one of the initial biotransformation pathways for arylamine and heterocyclic amine carcinogens.

REFERENCES:

1) Frick, C., (2004) J. Biol. Chem. 279 (30), 31131-31138.

品牌介绍

ProSci Inc.始终开放以支持研究需求，同时确保我们员工的健康和安全。ProSci拥有广泛的冠状病毒SARS-CoV-2 重组蛋白和抗体产品组合，并将继续积极开发新的冠状病毒产品。此外，ProSci的定制抗体服务也保持开放状态，以支持研究团体开发研究工具，诊断，疗法和疫苗。